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of Southeast Asian Nations (ASEAN) Emerging Infectious 
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throughout the research process. We are most grateful to Eliette 
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amongst experts and policy-makers from the two regions. The 
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Part of this research report has been published as an article 
under the title “Communicable diseases and governance: A tale 
of two regions”, by Marco Liverani, Piya Hanvoravongchai and 
Richard J. Coker, in the “Global Public Health: An International 
Journal for Research, Policy and Practice”, Volume 7, Issue 6, 
2012, Taylor & Francis Ltd, www.tandfonline.com. An abstract 
of the article is reprinted with permission of the publisher and 
appears at the end of this report. It includes a link to the full 
article on the publisher’s website.
ACKNOWLEDGMENTS
6This report provides an overview of regional mechanisms of communicable disease prevention 
and control in the European and Asian contexts. Over 
the past decades, the consolidation of projects of 
political and economic co-operation in both regions 
has created institutional platforms for the shaping 
of public health policies and programmes beyond 
national borders. In Europe, the European Union (EU) 
has become an increasingly important actor for the co-
ordination of national efforts. While response to public 
health threats largely remains a competence of EU 
Member States, the legal and organisational structure 
for interventions at the EU level has been considerably 
strengthened. The establishment of the European 
Centre for Disease Prevention and Control (ECDC) in 
2005 was a significant step in this direction. In Southeast 
Asia, similar developments have been fostered by 
two main factors. First, as in Europe, the growth of 
institutions for political and economic co-operation 
has provided the bases for closer collaboration in 
public health. Second, geographic areas in the region 
that encompass more than one country, such as the 
Mekong Basin, have been particularly prone to disease 
outbreaks of international concern. Thus, the support 
and co-ordination of surveillance and response 
programmes in regional hotspots of epidemic 
activity has become a priority of funding agencies 
and health organisations. This report aims to gain an 
understanding of these developments, including an 
overview of institutional mechanisms for Asia-Europe 
cross-regional co-operation. In a comparative fashion, 
it aims to (1) outline the background context in both 
regions; (2) provide an overview of achievements, key 
issues and gaps; (3) map experience and expertise 
exchange between Asia and Europe; and (4) identify 
areas for future research and co-operation.
ExECuTivE SuMMAry
7Recommendations
In both regions, the policy drive to harmonise, 
integrate and co-ordinate ought to be balanced with a 
concern with differences between the capacities and 
economic needs of individual countries, sub-regional 
areas and local communities.
High population mobility across Asia and Europe, 
and the resulting risks of disease transmission, should 
be given more attention. Further research should 
examine past and current patterns of inter-regional 
mobility and their implications for the prevention and 
control of infectious diseases.
There is wide room for closer co-operation 
between Asian and European partners. For example, 
Asian experts have gained considerable experience 
in management of public health crises after the 
outbreaks of Severe Acute Respiratory Syndrome 
(SARS) and avian influenza H5N1; this can be a 
highly valuable resource to European experts and 
policy-makers. On the other hand, the EU model of 
supranational integration and health co-operation 
can provide a useful reference to Asian partners, also 
in consideration of current efforts to build an ASEAN 
Community by 2015.
There are already a number of successful 
collaborations between Asian and European partners. 
However, current initiatives tend to be short-termed. 
Long-term exchanges would foster deeper links 
between the two regions (e.g., postdoctoral fellowships, 
professional positions). Also, the institutionalisation 
of health co-operation at the highest-level of policy 
making would provide stronger bases to co-operation. 
In particular, the establishment of an ASEM regular 
meeting of health ministers would fill an important gap 
in the ASEM process.
Key Findings
In the European context there is a process of 
increasing rationalisation and centralisation of 
regional policies and programmes, driven by the 
leading role of the EU. In Southeast Asia, the situation 
is more fragmented, as many institutional actors and 
organisations are involved at the regional level, often 
with different agendas and approaches.
EU communicable disease policies are 
underpinned by a legal framework and regulatory 
processes, albeit in a rather unsystematic way and 
mainly through case law. In Southeast Asia, regional 
programmes are based on informal agreements and 
“soft law”.
Permanent institutions at the EU level facilitate 
continuity and consistency of regional activities. By 
contrast, most programmes in Southeast Asia have 
a temporary mandate. The latter approach is more 
flexible, but creates problems of capitalisation.
In Southeast Asia, there is a more comprehensive 
approach to regional co-operation in public health, 
ranging from co-ordination of national preparedness 
plans to the community level. In the EU, interventions 
and programmes tend to focus on high-level policy-
making.
International co-operation in Southeast Asia is 
often based on a distinctive model of regional division 
of labour, whereby the initiative and sense of ownership 
of member countries is fostered and valued. In the EU, 
there is more emphasis on the authority and role of 
the central agencies — the European Commission, the 
ECDC and specialised agencies such as the European 
Medicines Agency (EMA) and the European Food Safety 
Authority (EFSA).
In the past decade, the establishment of platforms 
for dialogue and co-operation between the states of 
the European Union and Asia — such as the Asia-
Europe Meeting (ASEM) process and the EU-ASEAN 
Dialogue — has provided new bases for inter-regional 
relations. While these agreements are based upon 
informal discussion and exchanges, they have great 
potential to promote and facilitate health co-operation 
across the two regions.
Executive Summary
8The emergence or  
re-emergence of infectious 
diseases with pandemic 
potential has brought 
renewed attention to the 
key role of international 
collaboration and  
co-ordination. 
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9The importance of international co-operation for the prevention and control of communicable diseases 
has long been recognised by governments and 
health authorities. Since the International Sanitary 
Conferences of the mid-19th century, it has become 
apparent that the wide spread of diseases cannot be 
only a matter of national governance but requires 
standard procedures, transnational communication 
channels and common agreements on the handling 
of infected travellers across borders (Howard-Jones 
1975; Fidler 2005).
In the past decade, the emergence or re-emergence 
of infectious diseases with pandemic potential 
has brought renewed attention to the key role of 
international collaboration and co-ordination. Driven 
by these concerns, the World Health Organization 
(WHO) has made several efforts to strengthen global 
surveillance systems and promote the collective 
action of governments and national authorities. As 
former director of WHO’s Communicable Diseases 
Programme David Heymann (2006) put it, the 
changing landscape of international health has 
intensified the need to place “global solidarity above 
national sovereignty”.
Besides the global dimension of disease surveillance 
and control, international co-operation has also 
developed at the regional level. The regionalisation 
of public health policies has been driven by three 
main factors. First, geographic areas encompassing 
more than one country have been particularly prone 
to communicable diseases outbreaks. In recent years, 
for instance, Southeast Asia has been the epicentre 
of highly pathogenic diseases such as Severe Acute 
Respiratory Syndrome (SARS) and highly pathogenic 
avian influenza H5N1. Thus, the support and co-
ordination of surveillance and response programmes 
in regional hotspots of epidemic activity has become a 
priority of funding agencies and health organisations. 
Second, since its establishment in 1948, the WHO has 
operated through a decentralised system of regional 
offices, which are responsible for health programmes 
and policies in six wide geographic areas (Africa, 
Americas, Eastern Mediterranean, Europe, Southeast 
Asia and Western Pacific). Third, the consolidation 
of projects of political and economic co-operation 
in several parts of the world has provided new 
institutional bases for the development of public health 
policies at the regional level. Indeed, the prevention 
and control of infectious diseases has become an 
area of governance for regional organisations such 
as the European Union (EU), the Association of 
Southeast Asian Nations (ASEAN), the Asia-Pacific 
Economic Cooperation forum (APEC), the South Asian 
Association for Regional Cooperation (SAARC), the 
Caribbean Community (CARICOM) and the Southern 
Common Market (MERCOSUR).
This report aims to offer an overview of these 
developments in the European and Asian contexts. 
Despite many differences in health priorities and 
capacities, in both regions political developments 
and recent public health crises have contributed 
to strengthening mechanisms for international co-
operation. The first part of the report focuses on the 
European context, discussing the evolution of EU 
policies from early interventions in the 1990s to the 
establishment of the European Centre for Disease 
Control and Prevention (ECDC). The second part 
examines regional co-operation in Southeast Asia, 
during and after the SARS crisis. The third part focuses 
on three institutional mechanisms for Asia-Europe co-
operation in public health: the EU-ASEAN Dialogue, 
the Asia-Europe Meeting (ASEM) process and the EU 
International Cooperation framework. Finally, the last 
section provides a comparative analysis of regional 
mechanisms in Europe and Southeast Asia, with a 
number of recommendations to inform the research 
and policy agenda. 
Introduction
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Surveillance Network (MBDS), the Greater Mekong 
Subregion Communicable Disease Control Project 
(GMS-CDC) and the Surveillance and Investigation 
of Epidemic Situations in South-East Asia (SISEA) 
project of the Institut Pasteur Network. While these 
three programmes were established under different 
organisational and institutional arrangements, they 
have all been driven by a pledge to strengthen 
regional integration.
Finally, this research set out to document cross-
regional co-operation across Europe and Asia. Again, 
this is a broad and complex issue, which includes a 
diverse range of institutional arrangements, including 
bilateral agreements, various forms of collaborations 
between international organisations and individual 
countries, and inter-regional platforms. We focused on 
inter-regional platforms, as we were mainly interested 
in broad region-to-region processes, in keeping with 
the overall objectives of the study.
To gain an understanding of the aforementioned 
developments, we relied on various sources of empirical 
material, including “grey literature” in English 
language, which is available in the public domain (e.g., 
reports and legal and policy documents), academic 
articles, conference papers and semi-structured 
interviews with key informants in relevant institutional 
settings. Face-to-face interviews were conducted at 
the ASEAN Secretariat in Jakarta, Indonesia. Phone 
interviews were conducted with experts and policy-
makers at the ECDC, the Directorate General for 
Health and Consumers of the European Commission. 
Interviews were also conducted with key informants at 
the Institut Pasteur, the Asian Development Bank, and 
the Mekong Basin Disease Surveillance Programme.2 
This study was commissioned to examine regional 
mechanisms of communicable disease control in 
Asia and Europe. The research focus, on large and 
diverse units of analysis such as “Asia” and “Europe”, 
posed particular methodological challenges, also in 
consideration that the project was conducted under 
tight time constraints — between March 2010 and 
June 2010.1 In light of this, we had to select a limited 
number of case studies in the two regions, which could 
however shed light on emerging trends and wider 
processes. In researching the subject at the European 
level, we found that the European Union is becoming a 
major part of the public health infrastructure in Europe; 
yet this development has largely been unexplored in 
public health studies (Greer and Mätzke 2012). Thus, 
we decided to focus on EU communicable disease 
policy, aware that other institutions have had a key role 
in promoting international co-operation in the region, 
especially the WHO Regional Office for Europe.
In the Asian context, the situation is more fragmented. 
While regional integration in Europe is driven by a process 
of increasing centralisation, under the patronage and 
leading role of the European Commission, in Asia many 
organisations are involved in the promotion of health 
co-operation at different sub-regional levels, including 
the Association of South East Asian Nations (ASEAN), 
the South Asia Association for Regional Cooperation 
(SAARC) and the forum for Asia Pacific Economic 
Cooperation (APEC), along with the WHO Regional 
Office for South-East Asia and the WHO Regional 
Office for the Western Pacific. Given this complexity, 
we limited the analysis to Southeast Asia and the 
role of ASEAN in particular. The rationale behind 
this choice is that Southeast Asia has recently been 
the epicentre of diseases of international concern, 
such as SARS and H5N1, which have required closer 
international co-operation and innovation in public 
health approaches. In particular, ASEAN has emerged 
as an important and constructive player for the co-
ordination and integration of regional activities. In 
addition to ASEAN, many other organisations are active 
in regional programmes, including research institutes, 
governmental and non-governmental agencies. While 
the aim is not to draw a comprehensive map of all 
initiatives, we briefly presented three examples of 
recent programmes that can illustrate wider issues 
at the regional level: the Mekong Basin Disease 
Methodological Issues and Materials
Introduction
1 The manuscript was updated and revised in October 2012.  
2 Extracts from this report were included in two published articles (Liverani et al. 2012; Liverani and Coker 2012).
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The consolidation of the 
process of European 
integration has provided an 
important political platform to 
shape public health strategies 
at the regional level. 
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rEGiONAL iNTEGrATiON  
iN EurOPE
In the past two decades, the consolidation of the process of European integration has provided an important 
political platform to shape public health strategies at 
the regional level. While until the early 1990s health 
policy had a marginal role in the overall framework of 
the European Community, after the establishment of 
the European Union in 1992 public health has become 
a more prominent item on the agenda of European 
policy-makers. This development can be explained as 
a result of different factors, including growing mobility 
of people and traded goods within the European space 
as well as the policy impact of public health crises 
such as bovine spongiform encephalopathy (BSE), 
better known as “mad cow” disease, and the threats 
of pandemic influenza and bio-terrorism. In 2005, 
the establishment of the European Centre for Disease 
Prevention and Control (ECDC) has further contributed 
to the “Europeanisation” of communicable disease 
control by providing the EU with a centralised structure 
that co-ordinates European surveillance networks. 
The following section aims to offer an overview of these 
processes, from early developments to the foundation 
of the ECDC.
National networks for prevention and control of 
communicable diseases have existed in Europe since 
the post-World War II period. In line with with World 
Health Organization (WHO) recommendations, in the 
1950s health authorities in some countries established 
national centres for collection, analysis and report of 
epidemiological and virological information. For many 
years, however, efforts were highly fragmented. A 
detailed review published by WHO Regional Office for 
Europe in 1984 noted that national standards were 
very different and there were few exchanges across 
national borders (Velimerovic 1984).
During the 1980s, this situation began to change. 
Technological advances in electronic communications 
enabled the creation of new linkages between research 
centres, institutions and individual practitioners 
across wide geographic areas. Under the initiative of 
directors of national surveillance centres, a number 
of networks were established to monitor and study 
the epidemiology of specific diseases at the European 
level, including HIV/AIDS (EuroHIV), tuberculosis 
(EuroTB), legionella infections (EWGLI) and food-borne 
infections (SALMNET). At the same time, the European 
Community supported experimental projects on 
disease surveillance. The network Eurosentinel (1987–
1991), funded by the European Commission under 
the second Framework Programme for research and 
development, aimed to create an international system 
of sentinel practices and thus to produce a “unique 
knowledge which is only available through comparisons 
of health status, patterns of care, resources, and 
expenditure in different countries” (WHO 1990). While 
the implementation of Eurosentinel highlighted many 
Early Developments
Technological advances in 
electronic communications 
enabled the creation of new 
linkages between research 
centres, institutions and 
individual practitioners across 
wide geographic areas.
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differences in diagnostic criteria and systems of 
classifications, the comparative analysis of data on 
four diseases (influenza, mumps, measles and HIV) 
contributed to better understanding epidemiological 
trends across Europe. In addition, Eurosentinel laid 
down the bases for the development of similar schemes 
in the following years, such as the ENS-CARE Influenza 
system and the European Influenza Surveillance 
Scheme (EISS). ENS-CARE Influenza was created in the 
early 1990s under the initiative of WHO Europe and with 
the technical support of DG-XIII Telecommunications 
of the European Commission. ENS-CARE consisted 
of an electronic network of national influenza centres 
that provided information for national administrations 
and public health institutions. It also established an 
early warning system based on epidemiological data 
that were collected by national institutes and WHO 
Europe (Fleming and Cohen 1996). Following this 
experience, EISS was launched in 1996. Over the years, 
EISS has involved thousands of sentinel physicians and 
influenza reference laboratories in several countries. 
Most notably, it has brought many improvements in the 
management of international collaboration, including 
the definition of common rules for reporting clinical 
incidence, the use of quality control programmes, and 
more efficient exchange of epidemiological information 
through the website. Similar to its predecessors, 
however, the early implementation of EISS faced some 
important technical challenges, such as the difficulty 
to aggregate and compare data that are inevitably 
influenced by context-dependent variables, such as 
differences in healthcare systems, patterns of medical 
consultation and reporting behaviours (Fleming et al. 
2003) as well as the problem of securing sustained 
funding for surveillance.
In the 1990s, European co-operation on communicable 
diseases was further enhanced as a result of two 
important developments. On the one hand, directors 
of national surveillance centres established in 1994 
an informal advisory body to work with the European 
Commission and set up a European framework for 
communicable disease surveillance. Subsequently, 
this Charter Group developed new tools to support 
disease surveillance at the European level, including 
a printed and electronic surveillance bulletin called 
Eurosurveillance and a high-level training programme 
in field epidemiology called European Programme for 
Intervention Epidemiology Training (EPIET), which 
was aimed to create a cadre of senior epidemiologists 
sharing common methods and language. On the other 
hand, after the establishment of the European Union 
in 1992, the institutions of the European Community 
significantly increased their commitment to public 
health policy (MacLehose et al. 2002; Reintjes 
2008). This development can be explained in light 
of three convergent phenomena. First, the growing 
mobility of people and traded goods within the EU 
has facilitated the transnational spread of diseases 
and thus required increased co-operation and the 
harmonisation of surveillance procedures. This 
need has become more urgent after the latest 
rounds of enlargement, which expanded the EU to 27 
Member States and radically changed its geopolitical 
configuration (Coker et al. 2004). 
The growing mobility of people 
and traded goods within the EU 
has facilitated the transnational 
spread of diseases and thus 
required increased co-operation 
and the harmonisation of 
surveillance procedures.
Regional Integration In Europe
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Second, as the EU moves from a single economic 
market to a more political process of integration, 
public health is becoming more relevant on the 
agenda of European policy-makers. While the actual 
response to public health threats largely remains 
a competence and responsibility of EU Member 
States, the legal bases for community planning and 
interventions in this area have considerably been 
strengthened, although in a rather unsystematic way 
and mainly through case law (McKee and Mossialos 
2006; Greer 2008; Lamping and Steffen 2009).3 Third, 
the public health emergency of BSE in the late 1990s, 
as well subsequent threats of pandemic influenza, 
SARS, and bioterrorism, have provided further impetus 
to the development of transnational mechanisms for 
surveillance and response.
In this changing context, in 1998 the European 
Parliament and the Council of the European Union 
made a formal decision to set up a European policy 
network for epidemiological surveillance and control of 
communicable diseases, and a new early warning and 
response system (European Parliament and the Council 
1998).4  Following this decision, the Commission set 
up new Dedicated Surveillance Networks (DSN) or 
improved networks that were already in operation. In 
practice, each network collects and analyses data on 
specific diseases beyond routine surveillance, including 
detection of novel strains for the study of resistance 
mechanisms (Ternhag et al. 2004). In addition, a web-
based Early Warning and Response System (EWRS) 
was established to ensure rapid communication in 
case of public health emergencies of international 
concern (European Commission 2007, 2009).
3 The consolidated version of the Lisbon Treaty (2008) states that the European Union “shall encourage co-operation between the 
Member States to improve the complementarity of their health services in cross-border areas” (TFEU, Article 168).
4 The criteria for selection of communicable disease to be covered by the European surveillance network were: 1) diseases that 
cause, or have the potential to cause, significant morbidity and/or mortality across the Community, especially where the prevention 
of the diseases requires a global approach to co-ordination; 2) diseases where the exchange of information may provide early 
warning of threats to public health; 3) rare and serious diseases which would not be recognised at national level and where 
the pooling of data would allow hypothesis generation from a wider knowledge base; 4) diseases for which effective preventive 
measures are available with a protective health gain; 5) diseases for which a comparison by Member States would contribute to 
the evaluation of national and Community programmes (European Commission 2000).
The access to the system is secured 
and is limited to the formally appointed 
contact points. […] following notification 
from Member States, the contact point 
receives a login and a password from 
the Commission to access the system, 
and full authorisation to write and read 
messages. When a message is posted on 
the system, it is automatically circulated 
to all EWRS contact points, and the 
network (Commission, Member States, 
acceding and the EEA countries, and 
ECDC) is informed at the same time of 
how the situation is progressing and of 
the measures planned or undertaken at 
national level to respond to the specific 
event (Guglielmetti et al. 2006).
THE EARLY WARNING AND 
RESPONSE SYSTEM (EWRS)
Regional Integration In Europe
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5 To perform these tasks, the Centre is structured in four technical units: (1) Scientific Advice; (2) Surveillance; (3) Preparedness 
and Response; and (4) Health Communication.
of dedicated surveillance networks, the maintenance 
of databases for epidemiological surveillance, and the 
technical and scientific evaluation of prevention and 
control measures at the EU level.5 In the long term, 
the Centre aims to standardise methods and improve 
reporting in all EU countries, especially with regard to 
case definitions, data collections, laboratory protocols 
and classifications.
The creation of ECDC reflects an important change 
in EU policies on communicable diseases. Physically 
located in a dedicated building near Stockholm and 
staffed with about 300 professionals, the Centre 
embodies the shift from a fragmented process to 
centralisation. Since its foundation, the Centre 
has gradually incorporated the co-ordination of 
services and activities which were initially organised 
through a variety of different arrangements and 
responsibilities, including the Disease Surveillance 
Networks (see Table 1), the European Programme 
for Intervention Epidemiology Training (EPIET) and 
the bulletin Eurosurveillance. As the multi-annual 
plan for the years 2007–2013 states, the ECDC 
aims to become “the focal point for communicable 
disease surveillance in the European Union and the 
authoritative point of reference for strengthening 
surveillance systems in the Member States” 
(ECDC 2008). This goal, moreover, is part of a wider two-
pronged strategy on communicable diseases control 
In 2005 the EU strategy on communicable diseases 
control was further consolidated after the 
establishment of the European Centre for Disease 
Prevention and Control (ECDC), an independent 
agency of the European Commission, with the mandate 
“to identify, assess and communicate current and 
emerging threats to human health from communicable 
diseases” (European Parliament and the Council 2004). 
According to its founding regulation, this new centre 
has a wide range of tasks, including the collection and 
analysis of relevant scientific data, the management 
The European Centre for Disease 
Prevention and Control (ECDC)
Regional Integration In Europe
The creation of ECDC reflects 
an important change in EU 
policies on communicable 
diseases. Physically located 
in a dedicated building near 
Stockholm and staffed with 
about 300 professionals, the 
Centre embodies the shift 
from a fragmented process to 
centralisation. 
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whereby the ECDC is charged with risk assessment 
while the European Commission is charged with risk 
management, in shared responsibility with the EU/EEA 
Member States. In the event of public health threats of 
supranational concern, the ECDC shall provide a risk 
assessment to the Commission (namely, the Health 
Threats Unit of DG Health and Consumers), which 
has the mandate to support response and co-ordinate 
the action of Member States, in accordance with the 
principle of subsidiarity.6
Antimicrobial resistance and healthcare-associated infections
European Antimicrobial Resistance Surveillance Network (EARS-Net)
European Surveillance of Antimicrobial Consumption Network (ESAC-Net)
Healthcare-Associated Infections Network (HAI-Net)
Food- and waterborne diseases and zoonoses
European Food- and Waterborne Disease and Zoonoses Network (FWD-Net)
European Legionnaires’ Disease Surveillance Network (ELDSNet)
HIV, STI, and blood-borne viruses
European HIV/AIDS Surveillance Network 
European Network for STI Surveillance 
European Hepatitis B and C Surveillance Network
Influenza
European Influenza Surveillance Network (EISN)
Tuberculosis
European Tuberculosis Surveillance Network
Vaccine preventable diseases and invasive bacterial infections
European Invasive Bacterial Disease Surveillance Network (EU-IBD) 
European Network for Pertussis Surveillance 
European Diphtheria Surveillance Network (EDSN) 
European surveillance network for selected vaccine-preventable diseases (EUVAC-Net)
Table 1. Dedicated Surveillance Networks
6 In EU law, the principle of subsidiarity maintains that the European Union should perform only those tasks that cannot be 
performed effectively at a more immediate or local level. More specifically, “Under the principle of subsidiarity, in areas which do 
not fall within its exclusive competence, the Union shall act only if and in so far as the objectives of the proposed action cannot be 
sufficiently achieved by the Member States, either at central level or at regional and local level, but can rather, by reason of the 
scale or effects of the proposed action, be better achieved at Union level” (TFEU 2008).
Regional Integration In Europe
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EU policies on infectious diseases are still evolving and 
taking shape. Over the past decade, the consolidation 
of disease surveillance networks and their integration 
under a single body (ECDC) has contributed to improved 
monitoring and analysis of epidemiological patterns 
across a wide and diverse geographic space. EU 
agencies have also provided timely and authoritative 
scientific guidance to promote harmonisation in areas 
where coherence of approaches is crucial, such as 
pandemic preparedness plans. In co-operation with 
Member States and the WHO, the ECDC and the 
European Commission have developed advanced tools 
to evaluate, strengthen and harmonise national plans 
for moderate or severe pandemics, including “acid 
tests”, planning assumptions and agreed preparedness 
indicators (ECDC 2012). Such efforts are most needed 
to assist member countries that have less resources, 
expertise and public health capacities.
Yet, the establishment of a truly supranational 
framework for disease surveillance and control 
in Europe faces many challenges. First, disease 
monitoring may still be obscured by a variety of 
factors that affect data quality, such as differences in 
Achievements and Challenges
case definitions, access to or use of microbiological 
tests, care-seeking behaviours and referral practices 
(Ammon and de Valk 2006). In addition, surveillance 
networks may have different classifications from the 
ones that are used at the national level; age grouping 
can also vary between, for example, the WHO and a 
European network for the same disease (Ternhag et 
al. 2004). To address this gap, since 2002 the European 
Commission has issued guidelines for comparable case 
definitions, which are periodically updated as a result 
of changing epidemiological trends or new scientific 
knowledge (European Commission 2002). The work 
of the ECDC has also contributed to more uniformity 
in protocols and standards. However, a report noted 
that “additional extensive work is needed to improve 
the quality and comparability of EU-wide disease 
surveillance data” (ECDC 2008). Today, the ECDC has 
successfully implemented a common platform for 
integrated data management and analysis called the 
European Surveillance System (TESSy), but there is still 
much work to do in order to harmonise data collection 
and reporting practices across Member States.
Second, the EU has developed a solid structure for 
expert advice and risk assessment, but has still very 
limited authority to co-ordinate responses. Indeed, 
recommendations on risk management so far have 
hardly resulted in coherent strategies across Europe, 
as illustrated by major discrepancies in national 
responses to pandemic influenza H1N1 in 2009 (UK 
Health Protection Agency 2010a). Furthermore, despite 
many efforts of the European Commission, national 
ministries of health have failed to agree on the creation 
of a European stockpile of antivirals, which could be 
strategically distributed in the event of pandemic 
influenza. Regardless of the debated public health 
benefits of antiviral stockpiling, this failure indicates that 
prospects for large-scale public health interventions 
The consolidation of disease 
surveillance networks and 
their integration under a single 
body (ECDC) has contributed 
to improved monitoring and 
analysis of epidemiological 
patterns across a wide and 
diverse geographic space.
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at the European level are limited (European Union 
2006). Current plans to develop a mechanism for joint 
procurement of vaccines might provide an alternative 
instrument to redress imbalances between Member 
States and thus show the added value of interventions 
at the EU level (see box below). However, concerns 
have been expressed that such agreements should 
be carefully tailored to the individual needs and public 
health capacities in each country (UK Health Protection 
Agency 2010b).
Since the emergence of the threat of 
influenza A (H1N1), the Commission 
has urged all Member States to co-
operate closely to ensure that there are 
no gaps in vaccination coverage, which 
would compromise overall pandemic 
preparedness in the European Union. 
In order to promote equitable access to 
vaccines against pandemic (H1N1) 2009 
influenza, the Commission has worked 
on joint procurement arrangements 
with those Member States that have 
expressed an interest to participate. 
There are several benefits for 
contracting authorities engaging in joint 
procurement arrangements, including 
lower prices, administrative cost savings 
and the pooling of different expertise 
between the participating authorities. 
Agreements also included the possibility 
of resale between Member States of any 
excess amounts of vaccine (European 
Commission 2009).
JOINT PROCUREMENT OF 
VACCINES IN THE EU
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The rapid spread of SARS and 
avian influenza across national 
borders has emphasised the 
need for increased co-ordination 
and co-operation amongst 
governments in Southeast Asia. 
rEGiONAL iNTEGrATiON 
iN SOuThEAST ASiA
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Despite sustained national and international efforts and important achievements, many 
regions in Asia still suffer from heavy public health 
burdens — especially where “an interplay of 
socioeconomic, environmental and behavioural factors 
as well as population movements, foster the spread 
of communicable diseases, both within and across 
borders, and threaten international health security” 
(Narain and Bhatia 2010:162). In recent years, 
Southeast Asia in particular has been the epicentre 
of disease outbreaks of international concerns such 
as SARS and highly pathogenic avian influenza H5N1 
(Coker et al. 2011). While SARS was contained in June 
2003, avian influenza is still a public health threat 
(WHO 2010).
The challenge of communicable diseases in Southeast 
Asia has triggered a large international response. 
Philanthropic foundations, non-governmental 
organisations (NGOs), research institutes, government 
agencies and regional organisations have supported 
and implemented programmes to strengthen public 
health capacities in the region, including surveillance 
and response mechanisms. In addition, the rapid 
spread of SARS and avian influenza across national 
borders has emphasised the need for increased co-
ordination and co-operation amongst governments 
in Southeast Asia. To this aim, several programmes 
have included specific schemes to promote collective 
action in areas that are particularly prone to epidemic 
outbreaks, such as the Mekong Basin. On the other 
hand, the consolidation of projects for political and 
economic integration in the region has provided 
new institutional bases for the implementation of 
public health programmes at the regional level. In 
different ways, organisations such as the Association 
of Southeast Asia Nations (ASEAN), the Ayeyawady-
Chao Phraya-Mekong Economic Cooperation Strategy 
(ACMECS), and the Asia-Pacific Economic Cooperation 
forum (APEC) have all endorsed transnational 
co-operation for the prevention and control of 
communicable diseases.
Drawing a comprehensive map of such a diverse 
landscape of public health programmes would be a 
daunting task. In the previous section, we have seen 
that regional integration of communicable diseases 
policies in Europe is driven by a process of increasing 
centralisation and rationalisation, under the patronage 
and leading role of the European Commission. 
Unlike the European context, in Southeast Asia 
there is a patchwork of overlapping initiatives, often 
underpinned by different approaches, timeframes and 
agenda (see Table 2).
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Mekong Basin Disease Surveillance Project (MBDS)
Surveillance and Investigation of Epidemic Situations in South-East Asia Project (SISEA)
Greater Mekong Subregion Communicable Disease Control Project (GMS-CDC)
South East Asia Infectious Disease Clinical Research Network (SEAICRN) 
Asian Partnership on Emerging Infectious Diseases Research (APEIR) 
ASEAN+3 EID Programme
Timeframe
I : 2000–2003
II : 2003–2007
III : 2007–2010
Timeframe
2006–2011
Timeframe
2005–2009
Timeframe
2005–2010
Timeframe
2007 - present
Timeframe
I: 2004–2005
II: 2007–2009
Activities
Surveillance, training, capacity 
building, information sharing
Activities
Surveillance, training, capacity 
building
Activities
Surveillance, capacity building, 
information sharing, training
Activities
Research
Activities
Research, policy analysis
Activities
Surveillance, capacity building, 
policy analysis, training, 
information sharing
Main Funder
Rockefeller Foundation
Main Funder
French Development 
Bank
Main Funder
Asian Development Bank
Main Funder
US National Institutes of 
Health; Wellcome Trust, 
UK
Main Funder
Canada’s International 
Development Research 
Centre (IDRC)
Main Funder
AusAID
Coverage
Cambodia, China, Laos, 
Myanmar, Thailand and 
Vietnam
Coverage
Cambodia, China, Laos 
and Vietnam
Coverage
Cambodia, Laos and 
Vietnam
Coverage
Indonesia, Singapore, 
Thailand and Vietnam 
Coverage
Cambodia, China, 
Indonesia, Thailand and 
Vietnam
Coverage
Brunei, Cambodia, 
China, Indonesia, 
Japan, Korea, Laos, 
Malaysia, Myanmar, the 
Philippines, Singapore, 
Thailand and Vietnam
Table 2. Some examples of regional programmes in Southeast Asia
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Given this complexity, we focused on a selection of 
examples and developments, which can shed light 
on wider regional dynamics and processes. In the 
following sections, we first provide a brief overview of 
three recent programmes for communicable diseases 
control, which have all been characterised by a focus 
on regional integration. We then examine the role of the 
Association of Southeast Asia Nations (ASEAN) and its 
Emerging Infectious Diseases (EID) Programme. As 
we observed, especially after the SARS outbreak, this 
organisation has become an important institutional 
actor for the development and co-ordination of public 
health strategies at the regional level.
1) The Mekong Basin Disease Surveillance Project 
(MBDS)
The Mekong Basin Diseases Surveillance (MBDS) is a 
regional surveillance project, which was established 
in 2001 by the health ministries of Cambodia, China, 
Laos, Myanmar, Thailand and Vietnam, with the 
financial support of the Rockefeller Foundation. The 
initial project was structured around three main 
objectives and lasted until the end of 2010. In particular, 
MBDS aimed to (1) strengthen sub-regional disease 
surveillance and information exchange, (2) strengthen 
human resource development in field epidemiology, 
(3) establish sustainable national capacities in disease 
surveillance, outbreak investigation and response, 
and (4) provide information for health and social policy 
to reduce burden arising from priority diseases. 
The project was supported by a communication 
infrastructure linking countries at the national, 
provincial, district, community and village levels. 
Members relied on a system of periodic reports 
and cross-border meetings to facilitate information 
exchange and build trust between parties. As 
documented in evaluations, this project has been 
a successful example of regional co-operation and 
provided effective support to the implementation of the 
new International Health Regulations in participating 
countries (Kimball et al. 2008). Moreover, it operated 
through an innovative model of regional division of 
labour, whereby each member country was responsible 
for individual components of the overall framework: 
cross-border co-operation (Laos), human-animal 
sector interface and community-based surveillance 
(Vietnam), human resources development (Thailand), 
information and communication technology capacities 
(Cambodia), risk communication (Myanmar), and 
laboratory capacities (China). The project was 
completed in 2010; plans are currently being discussed 
to establish MBDS as a permanent foundation.
Regional Projects
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2) Greater Mekong Subregion Communicable 
Disease Control Project (GMS-CDC)
The Greater Mekong Subregion CDC project was 
launched in 2005 as a joint initiative of the WHO 
and the Asian Development Bank, which provided 
the largest share of the USD38 million budget. This 
project spanned over a period of five years and 
involved Cambodia, Lao PDR and Vietnam. It aimed 
to strengthen national health capacities — including 
institutional structures, health policy, laboratory 
facilities and human resources — and to develop 
integrated systems of disease surveillance, response, 
and preparedness. At the same time, the project 
aimed to establish sustainable transnational co-
operation through the endorsement of a common legal 
framework, the support of joint research projects, and 
the co-ordination of control measures across national 
borders. The whole approach was underpinned by 
“the three pillars of the regional co-operation” (ADB 
2008): (1) regional strategy, policy and mechanism for 
regional co-operation, (2) knowledge management 
and human resource development, and (3) cross-
border operations and health services.
Joint research projects have been one of the most 
successful outcomes of the GMS-CDC project. During 
its five years of operations, GMS-CDC linked together 
research institutions in Cambodia, Laos and Vietnam. 
The public health programme has been completed, but 
the project website (http://www.gms-cdc.org) is still 
active and provides updates on infectious diseases 
and related events at the regional level, including 
outbreaks notifications, notices of scientific meetings 
and technical documents.
3) Surveillance and Investigation of Epidemic 
Situations in South-East Asia (SISEA)
In 2006, the Institut Pasteur established the SISEA 
project in partnership with the French Development 
Agency (AFD) to develop surveillance and response 
to pathogenic agents with epidemic potential in 
Southeast Asia. The project was also aimed to 
strengthen collaborations between laboratories of 
the Institut Pasteur Network in Cambodia, China and 
Vietnam, plus the National Center for Laboratory and 
Epidemiology (NCLE) in Laos.
SISEA had three public health objectives: (1) improving 
the diagnostic capabilities of national referential 
laboratories and integrating them into a network, (2) 
strengthening national epidemiological surveillance 
systems, and (3) strengthening co-ordination at 
the national and regional levels. Furthermore, the 
project combined public health interventions (e.g., 
surveillance activities) with an investigative approach 
and the production of scientific output, in keeping with 
the strong research tradition of the Institut Pasteur. It 
also promoted development and sharing of technical 
expertise in participating institutes, including mobility 
of health professionals and scientists through 
international training programmes. It was completed 
in 2011.
Regional Integration In Southeast Asia
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The Association of Southeast Asian Nations (ASEAN) 
was established in 1967, when the prime ministers of 
five countries — Indonesia, Malaysia, the Philippines, 
Singapore and Thailand — signed a political 
agreement in Bangkok, Thailand to initiate a process 
of co-operation and thus to “accelerate the economic 
growth, social progress and cultural development in 
the region through joint endeavours in the spirit of 
equality and partnership” (ASEAN 1967). Although 
negotiations between member countries have always 
been dominated by the principle of non-interference, 
based on the absolute primacy of national sovereignty 
(the so-called “ASEAN way”), over its 40 years of 
existence ASEAN has contributed to important political 
achievements. For example, since 1967 there have 
been no major armed confrontation between ASEAN 
countries, and in early 1990s the organisation was 
instrumental in bringing peace between Vietnam and 
Cambodia after a decade-long conflict. Also, as the 
Cold War ended, ASEAN provided a platform to engage 
China and other major players in East Asia in a wider 
regional framework (Acharya 2007). Indeed, ASEAN 
has progressively enlarged to include 10 Southeast 
Asian nations as well as China, Japan and Korea in 
bilateral agreements known as the ASEAN+3 process. 
Moreover, beyond core political and economic issues, 
ASEAN countries have co-operated in other areas, such 
as environment, education, security and migration.
After the SARS outbreak in 2003, public health has 
become more prominent in ASEAN regional policies. 
As Thomas (2006) observed, “SARS demonstrated 
how quickly a domestic issue could transcend 
national boundaries and how, at the regional level, 
time and space were compressed, requiring faster 
response times and a better understanding of the 
situation in neighbouring countries”. In this context, 
ASEAN and SARS
ASEAN leaders demonstrated an unprecedented 
level of co-ordination (Curley and Thomas 2004). In 
April 2003 the Health Ministers of ASEAN countries 
agreed on a joint statement to foster “the sharing of 
experience and best practices between countries” and 
requested the ASEAN secretariat to develop an action 
plan for regional co-operation (ASEAN 2003a). Similar 
to the organisational structure of the MBDS project, 
specific tasks were allocated to individual countries. 
In particular, the ministers agreed to “request 
Indonesia, as co-ordinator of the ASEAN Disease 
Surveillance Network, to look into using the website 
to support the exchange of information among ASEAN 
and the +3 Countries”, to request Thailand, as the 
co-ordinator of the ASEAN Epidemiologic Network, 
“to strengthen regional capacity for epidemiological 
surveillance”, and to request Malaysia “to implement 
the ASEAN project on Strengthening Laboratory 
Capacity and Quality Assurance for Disease 
Surveillance” (ASEAN 2003a). In the following months 
and until the containment of the disease, political 
leaders and health officials agreed on other actions 
concerning the exchange of information, co-operation 
among front-line enforcement agencies (e.g. health, 
customs, labour, and transport agencies), and the 
harmonisation of travel procedures to ensure proper 
health screening at entry points.
In June 2003 Southeast Asia was declared SARS-free 
(Heymann 2006). Although decisions reached in the 
ASEAN+3 meetings were largely reactive, they were 
essential to organise and co-ordinate containment 
measures across national borders.7 Also, they created 
capacities, infrastructures and an information-
sharing network that can be, and has been, used in 
the event of other regional public health emergencies 
(Curley and Thomas 2004). 
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7 In April 2003 ASEAN made a bilateral agreement with China to exchange epidemiological data, carry out joint training programmes, 
sponsor high-level symposia and undertake common measures for immigration and customs control. In addition, China pledged 
RMB10 million to establish a special fund for bilateral co-operation programmes on SARS control and prevention (ASEAN 2003b).
level. Similar to the management of SARS, member 
countries were responsible for individual projects in the 
overall strategic plan. Furthermore, the programme 
developed innovative projects to address the social, 
economic and cultural dimensions of communicable 
diseases in Southeast Asia, including projects on 
gender-specific risk factors, the involvement of local 
communities, and disease prevention and control in 
holiday destinations.
In addition to the EID programme, the ASEAN 
Secretariat co-ordinates a range of activities on 
planning and preparedness for pandemic influenza. 
In 2007, a working group on pandemic preparedness 
was established with the support of the United 
States Agency for International Development 
(USAID) to conduct multi-sector evaluations of 
national preparedness plans and provide technical 
advice. Further, the Japanese government provided 
the ASEAN Secretariat with a stockpile of 500,000 
courses of antivirals (Tamiflu) plus a large quantity of 
personal protective equipment, to be transferred to 
ASEAN member countries in the event of pandemic 
influenza. As part of these initiatives, in 2007 the 
ASEAN Secretariat, the government of Cambodia, 
the WHO, the government of Japan and selected 
logistics companies jointly conducted a simulation 
exercise called PanStop, to practise and evaluate the 
ability of various partners to work together in a rapid 
containment operation. This simulation was followed 
by other exercises in 2008 (the Philippines) and 2009 
(Malaysia), which assessed the level of preparedness 
and co-ordination in individual countries.
The Emerging Infectious Disease Programme of 
ASEAN+3, set up in 2004 to provide an additional 
instrument for infectious disease control in Southeast 
Asia, has been a positive outcome of early efforts 
towards regional co-operation. Supported by the 
Australian Agency for International Development 
(AusAID), this programme has developed many 
activities to strengthen health capacities, including 
training courses, seminars and workshops, promotion 
of closer links between human and animal health 
sectors, and exchanges of staff between laboratories in 
the region. In addition, the project website has served 
as a platform for sharing epidemiological data and 
surveillance information across Member States.
The EID Programme adopted an effective approach 
to address public health issues at the regional 
The ASEAN+3 Emerging Infectious 
Diseases (EID) Programme
The Emerging Infectious Disease 
Programme of ASEAN+3, set up 
in 2004 to provide an additional 
instrument for infectious disease 
control in Southeast Asia, has 
been a positive outcome of early 
efforts towards regional  
co-operation. 
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Regional programmes and the involvement of ASEAN 
have contributed to the establishment of more 
effective mechanisms for the prevention and control of 
communicable diseases in Southeast Asia. In the past 
few years, ASEAN member countries have made real 
progress in monitoring pandemic preparedness and 
developing multi-sector response plans.8 However, key 
challenges remain:
1) The regionalisation of communicable diseases 
control in Southeast Asia is a patchwork of overlapping 
initiatives with different approaches, organisational 
structures and timeframes. This fragmentation may 
reflect conflicting priorities of donor countries or 
institutions (Calain 2007), and may work against effective 
and efficient regional co-operation.
2) Many health professionals in the region recognised the 
need for enhanced co-ordination between programmes; 
yet there are no established mechanisms to enable 
collective action.9 Incidentally, informal exchanges and 
collaborations existed between the three sub-regional 
programmes that were briefly presented (MBDS, 
GMS-CDC, and SISEA). However, lack of co-ordination 
remains a concern in many other contexts.
3) The ASEAN Secretariat is well positioned to play a 
crucial role in promoting co-ordination and closer links 
between different stakeholders, agencies, policies and 
programmes. However, there are two major obstacles. 
First, unlike the EU, ASEAN has weak legal authority 
over national sovereignties. While the adoption of the 
ASEAN Charter in 2007 has strengthened the legal 
status of the organisation, it has also reasserted the 
Achievements and Challenges
fundamental principle of non-interference in domestic 
affairs of member countries. As a result, the ASEAN 
Secretariat might lack power to deal effectively with 
a politically sensitive issue such as infectious disease 
control. Second, public health and social issues in 
general still have a relatively low profile in the overall 
ASEAN agenda, which has hitherto centred mainly 
on economic integration. To be sure, one of the 
fundamental principles of the ASEAN Charter is “to 
enhance the well-being and livelihood of the peoples 
of ASEAN by providing them with equitable access to 
opportunities for human development, social welfare 
and justice”. However, there are no further references 
to health or healthcare in any articles of the Charter 
(ASEAN 2008b).
4) In Southeast Asia, the WHO has long supported 
public health programmes at the regional level. 
However, there are considerable differences between 
the coverage of WHO Regional Offices and the 
geographic scope of other organisations in the region, 
resulting in further fragmentation and incoherence 
between programmes. For example, while three 
ASEAN+3 countries are members of the WHO Regional 
Office for South-East Asia (Indonesia, Myanmar and 
Thailand), the other ASEAN+3 countries are members 
of the WHO Regional Office for the Western Pacific. 
Likewise, countries involved in regional initiatives 
such as GMS-CDC and MBDS are split between the 
two WHO regional offices. To bridge this gap, the WHO 
has implemented broad strategies covering both WHO 
regions, such as the Asia Pacific Strategy for Emerging 
Diseases (APSED). This ambitious programme was 
8 In April 2010, at the 16th ASEAN Summit in Hanoi, Vietnam, ASEAN heads of state reaffirmed their commitment to regional co-
operation on pandemic preparedness and asked national authorities to develop a regional preparedness plan.
9 The Memorandum of Understanding on the Mekong Basin Disease Surveillance project recognised that “there are many other 
existing co-operating mechanisms on disease surveillance and partnership building is one of the main focuses of this project” 
(MBDS 2001).
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designed to serve as a roadmap to strengthen core 
surveillance and response capacities, and thus 
help countries meet the requirements of the new 
International Health Regulations. As the action plan 
states, the focus on Asia Pacific was underpinned by 
the awareness that “the countries of the Asia Pacific 
Region are interconnected, they face similar threats to 
health, and their protection from those threats is only 
as strong as the weakest link” (WHO 2005). However, 
the feasibility of a common strategy in such a vast and 
diverse geopolitical space, spanning from India to New 
Zealand, remains problematic.
5) The SARS experience has taught an important lesson 
on the value of regional co-operation. Nonetheless, 
the drive to enhance integration, harmonisation and 
coherence of regional policies and approaches ought 
to be balanced with a careful consideration of the 
needs and capacities of individual countries, provinces 
and communities. Differing political and economic 
needs across the region (Pongcharoensuk et al. 2011), 
as well as imbalances between health systems and 
priorities, cannot be neglected in the process towards 
further integration.
The SARS experience has 
taught an important lesson 
on the value of regional co-
operation. Nonetheless, the 
drive to enhance integration, 
harmonisation and coherence of 
regional policies and approaches 
ought to be balanced with a 
careful consideration of the 
needs and capacities of individual 
countries, provinces and 
communities. 
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Inter-regional organisations 
have the potential to become 
key institutional actors in the 
landscape of international 
health, complementing the 
efforts of governments and other 
international organisations.
iNTEr-rEGiONAL  
CO-OPErATiON
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In the past decade, the consolidation of political relations between the states of the European Union 
and Asia has provided further institutional support 
for international co-operation in public health. 
After the outbreaks of SARS and avian influenza 
H5N1, prevention and control of communicable 
disease has often been discussed at inter-regional 
summits and high-level meetings. In such contexts, 
a range of initiatives have been launched to 
foster the sharing of knowledge and experience 
between health professionals and policy makers 
in Europe and Asia. In addition, plans to develop 
more integrated transregional approaches to 
surveillance, preparedness and response have 
been discussed. While these discussions are still 
at a very early stage, inter-regional organisations 
have the potential to become key institutional 
actors in the landscape of international health, 
complementing the efforts of governments and 
other international organisations.
The following section provides an overview of 
experience and expertise exchange between Asia and 
Europe, with a focus on three main contexts for inter-
regional co-operation: the EU-ASEAN Dialogue, the 
Asia-Europe Meeting (ASEM) and EU International 
Development programmes.
The beginning of inter-regional relations between the 
European Union and ASEAN dates back to the 1978, 
when ASEAN foreign ministers agreed to initiate a 
formal process of co-operation with the European 
Economic Community (EEC). This decision was 
institutionalised in 1980 after the signature of the 
ASEAN-EEC Cooperation Agreement. Supervised by 
the EC-ASEAN Joint Co–operation Committee (JCC), 
the EU-ASEAN relationship today is pursued through 
inter-regional ministerial meetings and individual co-
operation agreements (Gilson 2005).
Over the years, the EU-ASEAN relation has expanded to 
cover a wide range of policy domains, including trade, 
environmental issues, social and cultural development, 
and international terrorism. In the aftermath of recent 
public health threats, the need for closer co-operation 
in this area has been emphasised at summits and 
ministerial meetings. For instance, signatories 
to the Nuremberg Declaration in 2007 pledged to 
“promote closer co-operation to address the spread of 
communicable and infectious diseases, including HIV/
AIDS, SARS and avian influenza at the sub-regional, 
regional and global levels” (EU2007.de 2007). Likewise, 
at the 17th ASEAN-EU Ministerial Meeting, held on 27–
28 May 2009 in Phnom Penh, Cambodia, the ministers 
agreed to “intensify co-operation on infectious diseases 
such as HIV/AIDS, avian influenza and other high-risk 
pathogens, through cross-sectoral co-operation and 
integrated approaches to surveillance, prevention, 
risk mitigation, timely response and communication, 
with the objective of enhancing regional capacity and 
preparedness” (Council of the European Union 2009).
EU-ASEAN Dialogue 
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The Asia-Europe Meeting (ASEM) is another platform 
for the development of political and economic co-
operation between European and Asian states. This 
multilateral channel for inter-regional dialogue was 
established in 1996, after the first Asia-Europe summit 
in Bangkok, Thailand, and has progressively expanded 
to involve all EU countries, the ASEAN+3 countries as 
well as India, Pakistan, Mongolia, Russia, Australia, 
New Zealand, Bangladesh, Norway and Switzerland. 
The ASEM process is based on biannual meetings 
of the heads of state, but is constantly enlivened by 
economic, cultural and social initiatives, such as the 
People’s Forum and the Interfaith Dialogue (Dent 
2004).
In the ASEM context, public health was also identified 
as a key sector for co-operation. In October 2008, at the 
7th ASEM Summit in Beijing, China, the political leaders 
of 16 Asian and 27 European countries committed to 
promote bi-regional co-operation on prevention and 
control of pandemic influenza. The Initiative for Rapid 
Containment of Pandemic Influenza, launched in May 
2009 at the 9th ASEM Foreign Ministers’ Meeting in 
Hanoi, Vietnam, was the first outcome of this dialogue. 
The initiative is funded by the Japanese government 
and has two components: (1) a regional stockpile of 
antivirals for ASEM partners, stored in Singapore, 
which will be distributed in the event of pandemic 
influenza by the WHO in collaboration with the Japan 
International Cooperation System (JICS); (2) a public 
health network to promote co-operation between 
stakeholders and experts in Asia and Europe, which 
is managed by the Asia-Europe Foundation (ASEF), 
the only permanent physical institution under the 
ASEM framework. The public health network had 
Asia-Europe Meeting (ASEM)
In this context, both parties have launched new 
initiatives to foster co-operation across the regions. 
Since 2006, for instance, European and Asian scientists 
have participated in joint research projects as part of 
the EU Framework Programmes for research and 
development.10 In addition, workshops and seminars 
to share experience and knowledge between health 
professionals and scientists have been held in Asia 
and Europe. For example, in July 2009 the Singapore 
Immunology Network organised an Expert Meeting 
in Singapore on vector-borne infectious diseases 
involving more than 200 researchers from both the EU 
and Southeast Asia.
10 The EU Framework Programmes are multi-annual funding schemes to promote and support transnational co-operation in 
scientific research. While the largest share of the budget is allocated to research networks within the European Research Area, 
funds are available to support collaborations with non-EU partners.
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a thematic working group on infectious diseases 
and regional integration, which supported studies 
and expert meetings on this topic, including the 
research project from which this report draws. The 
ASEF Network has also a thematic working group on 
multi-sector pandemic preparedness and response, 
which focuses on building pandemic scenarios and 
developing strategies.
Inter-regional Co-operation
The International Development framework of the EU 
is another instrument for inter-regional co-operation 
on communicable diseases prevention and control. In 
2007, a communication of the European Commission 
stressed the need to support the strengthening of 
public health capacities in Asia, especially with regard 
to avian influenza:
The Commission has regularly indicated since 
2005 that its support to address the Avian Influenza 
(AI) crisis included a mid- and long-term vision: 
to link crisis response and development, to invest 
in institutional building and regional/global 
networking, to contribute in a sustainable way to 
epidemics and zoonosis control and to rehabilitate 
of affected sectors. Hence the Commission will 
pursue its co-operation with Asian and Central 
Asian countries on Highly Pathogenic and Emerging 
Diseases (HPED). Assistance will continue in the 
area of Avian Influenza control through sectoral 
dialogue, the reinforcement of veterinary and 
human health services at regional level, and the 
improvements needed at national level to facilitate 
regional integration.
— European Commission, “Regional Strategy for 
EU-Asia Cooperation” (2007–2013)
In 2008 this programmatic statement was followed by 
a decision to support a regional programme on highly 
pathogenic emerging diseases in Asia, in collaboration 
with the WHO, the International Organization for 
Animal Health (OIE) and the Food and Agriculture 
Organization of the United Nations (FAO). It must be 
noted that this programme is characterised by a strong 
emphasis on the promotion of regional integration, 
including interventions to assist the ASEAN and 
SAARC Secretariats to strengthen health capacities at 
the regional level (European Commission 2011). More 
specifically, the programme aims to establish regional 
co-ordination mechanisms for control of highly 
pathogenic and emerging diseases, to improve regional 
laboratory diagnostic capacities, and to strengthen 
surveillance and response capacity including regional 
networking. However, unlike initiatives within the 
frameworks of the EU-ASEAN Dialogue and the ASEM 
process, this programme is based on a donor-recipient 
relationship, rather than equal partnership.  
Finally, the European Commission has initiated a 
number of external collaborations in the food sector, 
such as the programme “Better Training for Safer 
Food” of the Directorate General for Health and 
Consumers. This programme provides training on 
the functioning of the Rapid Alert System for Food 
and Feed (RASFF), a surveillance tool that allows 
the European Commission and EU Member States to 
share information and take immediate action when 
dangerous food or feed is detected on the market or at 
the border. The RASFF network includes only European 
countries; however, the European Commission has 
organised workshops for participants in Africa, South 
America and Southeast Asia, with a view to introducing 
a similar system in other regions of the world. These 
workshops also include training on EU food law, animal 
health and welfare, and plant health regulations, to 
enable compliance with EU requirements and thus 
facilitate access of traded goods to the EU market 
(European Commission 2009).
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CONCLuSiONS
This report has examined regional and cross-regional 
mechanisms of communicable diseases prevention and 
control in Europe and Asia, with a focus on underlying 
institutional structures. It has discussed examples of 
good practice, challenges and prospects for the future. 
However, this is not a comprehensive analysis: while 
the report covers issues and developments that have 
a regional relevance, it has inevitably overlooked some 
important aspects. In particular, future research on the 
Asian context should focus on the role and activities of 
SAARC and APEC, as both organisations have played 
an important role in supporting regional programmes 
for infectious disease prevention and control. Further, 
a comparative analysis of SAARC, APEC and ASEAN 
would provide useful insights on the ways in which 
different institutional developments are influencing 
regional health co-operation in Asia.
Aware of these limitations, we summarise our findings 
and draw some conclusions by comparing approaches 
to regional integration in Europe and Southeast Asia. 
As we can see in Table 3, our analysis illustrates the 
emergence of two distinctive patterns of communicable 
disease control in the two regions:
Europe Southeast Asia
Process of rationalisation, driven by the leading role of 
the European Union; harmonisation and co-ordination
Legal framework, but unsystematic and mainly 
through case law; International Health Regulations
Permanent institutions. Continuity, but also “path 
dependence”
Emphasis on the central agencies 
Focus on high-level policies (national plans, national 
health agencies)
Patchwork of different initiatives, often underpinned 
by different approaches and agenda; lack of synergies
Soft law, informal agreements; International Health 
Regulations
Temporary arrangements. Problem of capitalisation, 
sustainability, and consistency
Reliance on the initiative and expertise of member 
countries
Focus on high-level policies, but also community 
level and social issues
Table 3. Regional mechanisms for communicable disease control in Europe and Southeast Asia
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Conclusions
In Europe, there is a clear process of rationalisation 
and centralisation at the regional level, directed by 
the leading role of the EU.11 This process facilitates 
the harmonisation of public health policies and 
the joint action of Member States. By contrast, in 
Southeast Asia there is a patchwork of independent 
initiatives, which are often informed by differing 
agendas and timeframes, resulting in duplication of 
efforts, overlapping of regional events and a general 
lack of synergies. Also, the geopolitical scope of such 
initiatives is considerably different, even at the sub-
regional level of the Mekong Basin.
In Europe, a legal framework and regulatory 
processes underpin the authority of the EU, although 
in a rather unsystematic way. In Southeast Asia, 
programmes on communicable diseases control are 
mainly based on “soft law” and informal agreements 
such as Memoranda of Understanding, in keeping with 
the “ASEAN way”. The adoption of the ASEAN Charter 
in 2007 has strengthened the legal status of ASEAN, 
but there are still no legal provisions on public health. 
Thus, the ASEAN Secretariat might lack sufficient power 
to implement effective regional policies in a sensitive 
policy domain such as public health. In both Asia and 
Europe, however, the International Health Regulations 
(2005) provide a shared legal instrument to strengthen 
prevention and control of communicable diseases.
The existence of permanent institutions at the EU 
level facilitates continuity and consistency of activities. 
Yet, it can also produce path dependence12 and lack 
of flexibility in case of emergencies (Greer 2008). 
Conversely, most programmes in Southeast Asia have 
a temporary mandate, usually no longer than five or six 
years. This approach is more flexible but cannot ensure 
continuity and capitalisation on previous experiences. 
In the European context, there is increasing 
emphasis on the role and authority of central 
agencies: the European Commission and ECDC 
as well as other EU health agencies such as the 
European Medicines Agency (EMA) and the European 
Food Safety Authority (EFSA). This approach facilitates 
harmonisation and concerted action, but has also 
the potential to encourage disinvestments at the 
national level, as national authorities may erroneously 
assume that responsibility for disease surveillance 
and control is shifting to the EU.13 In Southeast Asia, 
regional programmes have a decentralised structure, 
characterised by a regional division of labour in which 
countries are responsible for specific projects. The 
initiative of participating countries is valued, and their 
sense of ownership is a central part of the organisation 
of regional programmes.
In Europe, regional co-ordination of disease 
surveillance and response activities tends to focus on the 
central level of national plans and surveillance systems. 
In Southeast Asia, regional programmes have often 
involved a wider range of stakeholders, from central 
governments and authorities to local communities.
11 In some countries this development is counterbalanced by a process of devolution at the sub-national level (see, for instance, 
Rowland 2006).
12 In the social sciences and political theory, the concept of path dependence is used to explain the persistence of suboptimal 
outcomes as a result of decisions made in the past:  “Once a country or region has started down a track, the costs of reversal are 
very high. There will be other choice points, but the entrenchments of certain institutional arrangements obstruct an easy reversal 
of the initial choice” (Levi 1997, 28).
13 In the aftermath of the 2009 pandemic, ECDC Director Mark Sprenger pointed out: “During the 2009 Pandemic we have relied 
on systems established prior to the Pandemic. Maintaining strong and well resourced Institutes of Public Health is vital to better 
prepare and react to the next crisis. Here, microbiology laboratories and epidemiologists are critical” (ECDC 2010).
•
•
•
•
•
34
While differing approaches and institutional 
frameworks characterise regional developments in 
Europe and Asia, stakeholders in the two regions face 
similar challenges and issues, which should be given 
further attention in the research and policy agenda:  
Recommendations
Conclusions
The regionalisation of communicable disease policies 
cannot overlook specific needs in individual countries 
and communities. Discrepancies between policies and 
approaches are not only due to lack of political will or 
institutional gaps, but often result from differential 
access to resources or asymmetries in economic needs. 
Thus, the drive to co-ordinate and harmonise policy 
should be balanced with a careful consideration 
of different needs and resources at the national, 
provincial and community levels, including upstream 
economic drivers, health capacities, risk factors and 
health priorities.
Communicable diseases cross national 
boundaries as well as the geopolitical frames of 
regional programmes or organisations such as the 
EU or ASEAN. In this respect, it must be noted that 
there is high population mobility across the two 
regions, including documented and undocumented 
labour migration, tourism, business trips, refugees, 
asylum seekers and temporary migrations of 
international students and professionals. According 
to Eurostat, the statistical office of the European 
Union, on 1 January 2008, 30.8 million foreign citizens 
There is wide room for closer 
inter-regional co-operation 
between Asian and European 
partners. Asian experts have 
gained considerable experience 
on the management of public 
health crises after SARS and the 
recurrent threat of avian influenza 
H5N1 — and this can be highly 
valuable to European partners. 
•
•
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The institutionalisation of health 
co-operation at the highest 
level of policy making would 
ensure continuity of dialogue 
and exchanges. In particular, 
the establishment of an ASEM 
regular meeting of health 
ministers would fill an important 
gap in the ASEM process.
exchanges would foster deeper links between 
the two regions (e.g., postdoctoral fellowships, 
professional positions). In the field of research, for 
example, the establishment of an inter-regional 
research centre for the study of emerging infectious 
diseases would further contribute to this purpose. 
Also, the institutionalisation of health co-operation 
at the highest level of policy making would ensure 
continuity of dialogue and exchanges. In particular, 
the establishment of an ASEM regular meeting of 
health ministers would fill an important gap in the 
ASEM process.
Conclusions
14 According to the Declaration of ASEAN Concord II, signed by ASEAN governments in 2003, “An ASEAN Community shall be 
established comprising three pillars, namely, political and security co-operation, economic co-operation, and socio-cultural co-
operation that are closely intertwined and mutually reinforcing for the purpose of ensuring durable peace, stability and shared 
prosperity in the region”. With regard to the pillars socio-cultural co-operation, the Declaration states that “ASEAN shall further 
intensify co-operation in the area of public health, including in the prevention and control of infectious diseases, such as HIV/AIDS 
and SARS, and support joint regional actions to increase access to affordable medicines” (ASEAN 2003c).
lived in the 27 EU Member States, of which 3.7 million 
were citizens of Asian countries (Eurostat 2009). 
Recent studies have brought renewed attention 
to the crucial links between migration, population 
mobility and communicable diseases (Gushulak 
2004; MacPherson et al. 2007). Further research 
should examine past and current processes of 
inter-regional mobility, the transition of human 
populations between different risk environments, 
and the implications of these processes for the 
prevention and control of infectious diseases.
There is wide room for closer inter-regional co-
operation between Asian and European partners. 
Asian experts have gained considerable experience on 
the management of public health crises after SARS 
and the recurrent threat of avian influenza H5N1 — and 
this can be highly valuable to European partners. On 
the other hand, there is a well-established system of 
supranational governance in the EU, which can provide 
a structural model to the development of regional 
organisations in Asia, also in consideration of current 
efforts to build an ASEAN Community by 2015.14
There are already valuable programmes of 
inter-regional co-operation between Asian and 
European partners, in association with institutional 
platforms such as ASEM and the EU-ASEAN 
dialogue. However, most initiatives tend to be 
short-termed, such as workshops, conferences 
and interim research exchanges. Long-term 
•
•
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Regional policies and programmes on communicable 
disease prevention and control are becoming an 
important component of global public health. In a 
comparative fashion, we examined the situation in the 
European and Southeast Asian contexts, with a focus on 
the underlying institutional and political backgrounds 
underpinning the regionalisation of planning and 
interventions. Our findings document the emergence 
of two distinctive models of regional integration. While 
in Europe there is a process of institutionalisation 
and centralisation, in Southeast Asia the landscape 
of regional cooperation is characterised by the 
proliferation of many provisional projects, based on 
loose agreements and a decentralised structure that 
emphasises the initiative and sense of ownership 
of member countries. These two approaches, we 
conclude, reflect wider differences of political culture 
between supranational integration in Europe and 
intergovernmental agreements in Southeast Asia.
Source: http://www.tandfonline.com/doi/abs/10.1080/
17441692.2012.685487
Full article: http://www.tandfonline.com/doi/full/10.1
080/17441692.2012.685487
Article Abstract
Asia-Europe Foundation (ASEF)
The Asia-Europe Meeting (ASEM)
The Asia-Europe Foundation (ASEF) promotes understanding, strengthens 
relationships and facilitates cooperation among the people, institutions and 
organisations of Asia and Europe. ASEF enhances dialogue, enables exchanges 
and encourages collaboration across the thematic areas of culture, education, 
sustainable development, economy, governance and public health. ASEF is a not-
for-profit, intergovernmental organisation located in Singapore. Founded in 1997, it 
is the only institution of the Asia-Europe Meeting (ASEM). Together with about 700 
partner organisations ASEF has run more than 600 projects, mainly conferences, 
seminars and workshops. Over 17,000 Asians and Europeans have actively 
participated in its activities and it has reached much wider audiences through its 
networks, web-portals, publications, exhibitions and lectures. 
For more information, please visit www.asef.org
Asia-Europe Meeting (ASEM) is an intergovernmental forum for dialogue and 
cooperation established in 1996 to deepen relations between Asia and Europe, 
which addresses political, economic and socio-cultural issues of common concern. 
ASEM brings together 49 member states (Australia, Austria, Bangladesh, Belgium, 
Brunei Darussalam, Bulgaria, Cambodia, China, Cyprus, the Czech Republic, 
Denmark, Estonia, Finland, France, Germany, Greece, Hungary, India, Indonesia, 
Ireland, Italy, Japan, Korea, Laos, Latvia, Lithuania, Luxembourg, Malaysia, 
Malta, Mongolia, Myanmar, the Netherlands, New Zealand, Norway, Pakistan, the 
Philippines, Poland, Portugal, Romania, Russia, Singapore, Slovakia, Slovenia, 
Spain, Sweden, Switzerland, Thailand, the United Kingdom, Viet Nam) plus the 
European Commission and the ASEAN Secretariat. 
For more information, please visit www.aseminfoboard.org
REGIONAL MECHANISMS OF 
COMMUNICABLE DISEASE CONTROL
IN ASIA AND EUROPE
www.asef.org
